To evaluate whether early drug treatment extends overall survival compared with delayed drug treatment with high-risk (chronic lymphocytic leukemia [CLL] newly diagnosed asymptomatic CLL/SLL patients.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina
Christopher Jensen
Lineberger Comprehensive Cancer Center
Clinical or Medical
Interventional
Cancer (Leukemia, Lymphoma)
Chronic Conditions
Immune System/Infections
23-2094
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
